Exagen (XGN) EPS (Diluted) Growth (1y) (2021 - 2026)
Exagen (XGN) EPS (Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 10.71% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 59.30% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 17.55% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 58.79% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -6.55% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -21.08% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -9.61% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 18.37% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 13.90% |
| 10 | Exagen | 156.59 Mn | 131.99 Mn | 12.22 Mn | 37.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.18% |
| Mar 31, 2026 | 17.75% |
| Dec 31, 2025 | -4.91% |
| Sep 30, 2025 | -12.16% |
| Jun 30, 2025 | -29.03% |
| Mar 31, 2025 | -7.98% |
| Dec 31, 2024 | 32.04% |
| Sep 30, 2024 | 15.37% |
| Jun 30, 2024 | 42.54% |
| Mar 31, 2024 | 60.67% |
| Dec 31, 2023 | 63.94% |
| Sep 30, 2023 | 34.10% |
| Jun 30, 2023 | 70.95% |
| Mar 31, 2023 | 53.31% |
| Dec 31, 2022 | -90.91% |
| Sep 30, 2022 | -16.56% |
| Jun 30, 2022 | -158.16% |
| Mar 31, 2022 | -112.54% |
| Dec 31, 2021 | -61.55% |
| Sep 30, 2021 | -24.34% |